Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Retained Earnings (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Retained Earnings data on record, last reported at -$118.1 million in Q3 2025.

  • For Q3 2025, Retained Earnings rose 33.11% year-over-year to -$118.1 million; the TTM value through Sep 2025 reached -$118.1 million, up 33.11%, while the annual FY2024 figure was -$164.0 million, 1171521.43% down from the prior year.
  • Retained Earnings reached -$118.1 million in Q3 2025 per COLL's latest filing, up from -$149.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $241000.0 in Q1 2025 and bottomed at -$312.2 million in Q1 2021.
  • Average Retained Earnings over 5 years is -$186.2 million, with a median of -$231.3 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: plummeted 1171521.43% in 2024, then soared 100.12% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$256.3 million in 2021, then decreased by 9.75% to -$281.3 million in 2022, then surged by 100.0% to $14000.0 in 2023, then tumbled by 1171521.43% to -$164.0 million in 2024, then grew by 27.99% to -$118.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$118.1 million in Q3 2025, -$149.6 million in Q2 2025, and $241000.0 in Q1 2025.